Two-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Two-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

Abstract Introduction To evaluate the real-world efficacy of aflibercept using the treat-and-extend (TnE) regimen in treating neovascular age-related macular degeneration (nAMD) and polypoidal choroidal vasculopathy (PCV), and to analyze biomarkers using optical coherence tomography (OCT) to predict...

Full description

Bibliographic Details
Main Authors: Chu-Hsuan Huang, Tso-Ting Lai, Chang-Hao Yang, Yi-Ting Hsieh
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-11-01
Series:Ophthalmology and Therapy
Subjects:
Aflibercept
Age-related macular degeneration
Polypoidal choroidal vasculopathy
Treat-and-extend regimen
Vascular endothelial growth factor
Online Access:https://doi.org/10.1007/s40123-023-00850-6

Internet

https://doi.org/10.1007/s40123-023-00850-6

Similar Items